William Blair & Company’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $172K | Sell |
85,866
-15,000
| -15% | -$30K | ﹤0.01% | 1442 |
|
2025
Q1 | $252K | Buy |
100,866
+2,400
| +2% | +$6K | ﹤0.01% | 1312 |
|
2024
Q4 | $290K | Buy |
98,466
+10,000
| +11% | +$29.5K | ﹤0.01% | 1297 |
|
2024
Q3 | $266K | Hold |
88,466
| – | – | ﹤0.01% | 1331 |
|
2024
Q2 | $308K | Buy |
88,466
+20,000
| +29% | +$69.6K | ﹤0.01% | 1262 |
|
2024
Q1 | $362K | Sell |
68,466
-19,580
| -22% | -$103K | ﹤0.01% | 1185 |
|
2023
Q4 | $453K | Buy |
88,046
+2,873
| +3% | +$14.8K | ﹤0.01% | 1095 |
|
2023
Q3 | $446K | Buy |
+85,173
| New | +$446K | ﹤0.01% | 1095 |
|
2021
Q3 | – | Sell |
-407
| Closed | -$38K | – | 1947 |
|
2021
Q2 | $38K | Buy |
+407
| New | +$38K | ﹤0.01% | 1721 |
|
2020
Q1 | – | Sell |
-1,705
| Closed | -$35K | – | 1771 |
|
2019
Q4 | $35K | Sell |
1,705
-46,145
| -96% | -$947K | ﹤0.01% | 1524 |
|
2019
Q3 | $1.54M | Buy |
+47,850
| New | +$1.54M | 0.01% | 646 |
|